1. [O2–09–05]: SAFETY, TOLERABILITY, AND PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS OF PF‐06751979, A POTENT AND SELECTIVE ORAL BACE1 INHIBITOR: RESULTS FROM PHASE1 SINGLE AND MULTIPLE ASCENDING DOSE STUDIES IN HEALTHY YOUNG AND OLDER VOLUNTEERS. (1st July 2017) Authors: Qiu, Ruolun; Liu, Richann; He, Ping; Wills, Anne‐Marie; Tankisheva, Ekaterina; Alvey, Christine; Buckeridge, Clare; Bednar, Martin; Alexander, Robert C.; Chen, Danny Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 11 Page Start: P575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects. Issue 3 (22nd May 2018) Authors: Dawra, Vikas Kumar; Cutler, David L.; Zhou, Susan; Krishna, Rajesh; Shi, Haihong; Liang, Yali; Alvey, Christine; Hickman, Anne; Saur, Didier; Terra, Steven G.; Sahasrabudhe, Vaishali Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 3(2019) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of the effect of fluconazole and ketoconazole on the pharmacokinetics of tofacitinib in healthy adult subjects. Issue 1 (8th October 2013) Authors: Gupta, Pankaj; Chow, Vincent; Wang, Ronnie; Kaplan, Irina; Chan, Gary; Alvey, Christine; Ni, Grace; Ndongo, Marie‐Noella; LaBadie, Robert R.; Krishnaswami, Sriram Journal: Clinical pharmacology in drug development Issue: Volume 3:Issue 1(2014:Jan./Feb.) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of the potential interaction between tofacitinib and drugs that undergo renal tubular secretion using metformin, an in vivo marker of renal organic cation transporter 2. Issue 6 (23rd May 2014) Authors: Klamerus, Karen J.; Alvey, Christine; Li, Lei; Feng, Bo; Wang, Rong; Kaplan, Irina; Shi, Haihong; Dowty, Martin E.; Krishnaswami, Sriram Journal: Clinical pharmacology in drug development Issue: Volume 3:Issue 6(2014:Nov./Dec.) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Extended‐Release Once‐Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate‐Release Tofacitinib and Impact of Food. (6th October 2016) Authors: Lamba, Manisha; Wang, Rong; Fletcher, Tracey; Alvey, Christine; Kushner, Joseph; Stock, Thomas C. Journal: Journal of clinical pharmacology Issue: Volume 56:Number 11(2016) Page Start: 1362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Novel Application of the Two‐Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin. Issue 4 (25th March 2018) Authors: Raje, Sangeeta; Callegari, Ernesto; Sahasrabudhe, Vaishali; Vaz, Alfin; Shi, Haihong; Fluhler, Eric; Woolf, Eric J.; Schildknegt, Klaas; Matschke, Kyle; Alvey, Christine; Zhou, Susan; Papadopoulos, Dimitris; Fountaine, Robert; Saur, Didier; Terra, Steven G.; Stevens, Lloyd; Gaunt, Daniel; Cutler,... Journal: Clinical and translational science Issue: Volume 11:Issue 4(2018) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetics and Pharmacodynamics of Figitumumab, a Monoclonal Antibody Targeting the Insulin‐Like Growth Factor 1 Receptor, in Healthy Participants. (14th June 2013) Authors: Yin, Donghua; Sleight, Barbara; Alvey, Christine; Hansson, Arne G.; Bello, Akintunde Journal: Journal of clinical pharmacology Issue: Volume 53:Number 1(2013:Jan.) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetics and Pharmacodynamics of Figitumumab, a Monoclonal Antibody Targeting the Insulin‐Like Growth Factor 1 Receptor, in Healthy Participants. (24th January 2013) Authors: Yin, Donghua; Sleight, Barbara; Alvey, Christine; Hansson, Arne G.; Bello, Akintunde Journal: Journal of clinical pharmacology Issue: Volume 53:Number 1(2013:Jan.) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF‐06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects. Issue 5 (7th September 2017) Authors: Bhattacharya, Indranil; Pawlak, Sylvester; Marraffino, Shannon; Christensen, Jared; Sherlock, Sarah P.; Alvey, Christine; Morris, Carl; Arkin, Steven; Binks, Michael Journal: Clinical pharmacology in drug development Issue: Volume 7:Issue 5(2018) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗